Vivimed Labs gets approval from Uzbekistan government for two products

08 Mar 2021 Evaluate

Vivimed Labs has received approval from the Uzbekistan government for two products. The company has received approval for Bilastin tablets, which are used for the treatment of allergic Rhino conjunctivitis and Urticaria. Vivimed has also received approval for Orzole combi, which is used to treat gastrointestinal infections such as acute diarrhoea or dysentery, gynaecological, lung and urinary infections.

Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.

Vivimed Labs Share Price

16.75 -0.88 (-4.99%)
01-Jan-2026 09:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1711.05
Dr. Reddys Lab 1253.70
Cipla 1502.90
Zydus Lifesciences 909.80
Lupin 2088.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×